I can't seem to get Revlimid delivered from a Specialty Pharmacy on time to stay on schedule with my maintenance dose for Multiple Myeloma. This was not the case when I was taking the therapeutic dose before my Stem Cell Transplant in March 2022. Two changes have occurred since March 2022 I think may have impacted the insurance approval and delivery of Revlimid. First, a generic Revlimid was approved, but is just not readily available. The insurers started approving the generic Revlimid, which wasn't available, and created a slow down in approval of funding the drug by only approving the generic drug. The pharmacy at MD Anderson does not fill outpatient orders for Revlimid because it is so difficult to get approved. Second, the Biden administration made changes to address the overall cost of drugs for Medicare patients. I believe drug companies reacted with more strict requirements for financial payment for the drugs. Has anyone else noticed a slow down in approval of Revlimid and resulting delays in delivery?